ClinicalTrials.Veeva

Menu

Chinese Registry Study on Treatment of Cholecysto-Choledocholithiasis (CREST Choles)

Capital Medical University logo

Capital Medical University

Status

Unknown

Conditions

Gallstones
Cholecystolithiasis
Cholelithiasis
Choledocholithiasis

Treatments

Procedure: laparoscopic cholecystectomy
Procedure: laparoscopic common bile duct exploration
Procedure: endoscopic sphincterotomy
Procedure: laparoscopic transcystic common bile duct exploration

Study type

Observational

Funder types

Other

Identifiers

NCT02554097
CR-CREST Choles

Details and patient eligibility

About

Patients with gallstone and confirmed common bile duct stones are registered in this study. The three managements for common bile duct stones are endoscopic sphincterotomy (EST), laparoscopic common bile duct exploration (LCBDE) and laparoscopic transcystic common bile duct exploration (LTCBDE). Patients will be assessed at baseline, preoperative investigations, operative method, operative time, conversion to open procedure, intraoperative and postoperative complications, and the presence of retained and recurrent stones. All patients were followed up for 3 years by telephone interview ang outpatient visits. Abdominal US and liver function tests were carried out whenever any abdominal symptom appeared during the follow-up period. If there were unusual findings, magnetic resonance cholangiopancreatography(MRCP) was carried out.

Enrollment

2,700 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with age between 18 - 80 years.
  • Patients diagnosed with gallstones.
  • Patients diagnosed with common bile duct stone by one of the three exam (MRI、MRCP and CT).
  • Patients diagnosed with common bile duct stone by intro-operative cholangiography or transcystic exploration.
  • Patients accepted one of the three managements (EST+LC, LCBDE and LTCBDE).

Exclusion criteria

  • Combined with Mirizzi syndrome and intrahepatic bile duct stones
  • Previous EST/endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic biliary drainage (PTBD)
  • History of upper abdominal surgery.
  • Serious heart,brain,lung, metabolic diseases history.
  • Pregnant women
  • Unwillingness or inability to consent for the study.

Trial design

2,700 participants in 3 patient groups

EST+LC group
Description:
Patients accept the management of endoscopic sphincterotomy and laparoscopic cholecystectomy.
Treatment:
Procedure: laparoscopic cholecystectomy
Procedure: endoscopic sphincterotomy
LCBDE+LC group
Description:
Patients accept the management of laparoscopic common bile duct exploration and laparoscopic cholecystectomy.
Treatment:
Procedure: laparoscopic cholecystectomy
Procedure: laparoscopic common bile duct exploration
LTCBDE+LC group
Description:
Patients accept the management of laparoscopic transcystic common bile duct exploration and laparoscopic cholecystectomy.
Treatment:
Procedure: laparoscopic cholecystectomy
Procedure: laparoscopic transcystic common bile duct exploration

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems